OXON Epidemiology is a full-service global scientific and operational provider specialising in the generation of Real-World Evidence (RWE) via primary data collection, database and hybrid observational studies, pragmatic trials and systematic reviews of drugs and devices in all major therapeutic areas.
As a leader Contract Research Organization (CRO) we offer a combination of quality science and operational experience to provide life science companies worldwide with real-world evidence for safety, clinical effectiveness, drug use and HEOR endpoints.
With offices in London, Madrid and Kentucky, OXON applies world-class epidemiological and innovative technologies to help clients worldwide obtain high quality RWE for improving patient’s care and public health.
We focus on factors that are critical to our clients, pharmaceutical and medical devices companies, reducing the time to market and costs while maintaining quality. Our size allows us to be flexible and keep high quality people close to our clients, and our long-term alliances permit us to conduct observational studies worldwide.
We have led initiatives at ENCePP, presented on risk minimisation at the EMA, have academic links with the London School of Hygiene & Tropical Medicine and support from the eminent Professor of Medical Statistics, Stuart Pocock, and leading pharmaco-epidemiologists in Europe, becoming a preferred provider for several top-20 pharma companies.
CRO, RW studies & late-phase research | OXON Epidemiology
www.OxonEpi.com
info@OxonEpi.com